Hematology Billing Services for Infusion Practices
Hematology patients need specialized expertise and trust. We create compassionate, informative digital experiences that help hematology practices build trust with patients and referring physicians.
Medical Billing for Hematology
Our hematology and oncology billing services are built around the economics that define the specialty: infusions and expensive drugs. The infusion hierarchy decides which administration codes stack, J-code units must exactly match vials and documentation, and biologics rarely move without prior authorization. Under buy-and-bill, one denied drug claim can erase a week of margin, so we verify the coverage pathway before the chair is booked and reconcile every unit and waste entry before the claim goes out.
Infusion administration coding (96413/96415/96417) with the initial-service hierarchy applied correctly across multi-drug visits
J-code unit accuracy with NDC reporting and JW/JZ waste modifiers so drug reimbursement is never short-paid
Prior authorization and benefits investigation for biologics and specialty therapies before they're administered
Medical versus pharmacy benefit routing checked per drug and payer, so the practice never eats a misrouted dose
Same-day E/M alongside infusion billed with modifier 25 where a distinct evaluation is documented
Key CPT Codes in Hematology Billing
The codes that drive most of the revenue in this specialty, and what has to be right on each one.
| Code | Service | Billing Note |
|---|---|---|
| 96413 | Chemotherapy infusion, first hour | Ranks highest in the infusion hierarchy. Only one initial code per encounter, no matter how many drugs are given. |
| 96415 / 96417 | Chemo infusion, each additional hour / each additional sequential drug | Everything after the initial service bills as additional-hour or sequential add-ons. |
| 96365-96368 | Therapeutic (non-chemo) infusion family | Ranks below chemotherapy but above hydration. Choosing the wrong initial code underpays the whole visit. |
| 96360 / 96361 | Hydration, initial and each additional hour | Lowest in the hierarchy; only billable as initial when nothing else qualifies, and needs documented clinical need. |
| 96372 | Therapeutic injection, subcutaneous or intramuscular | Per injection, with the drug billed separately. Commonly under-captured on busy infusion days. |
| J-codes + NDC | Drug billing (e.g. J9299, J1745, J0897) | Units must match the vial size and documented dose exactly, with the NDC reported where payers require it. |
| JW / JZ modifiers | Discarded drug reported / no waste attested | Medicare requires one or the other on single-dose vials. Inconsistent waste reporting invites drug-billing audits. |
| 36415 / 36416 | Venipuncture / capillary collection | Small-dollar but high-frequency; routinely missed on visits where labs precede an infusion. |
Top Hematology Denials We Prevent
Two initial infusion codes billed for one encounter
How we prevent it: The infusion hierarchy is applied at coding, so one initial service is billed per visit and everything else goes out as sequential or additional-hour add-ons.
J-code units don't match the vial size or documented dose
How we prevent it: Drug units are reconciled against the administration record and vial size before submission, with NDC reporting applied where the payer requires it.
Missing JW or JZ waste reporting
How we prevent it: Every single-dose vial claim carries the correct waste attestation, which both protects reimbursement on discarded drug and keeps the practice out of audit patterns.
Biologic administered without authorization or on the wrong benefit
How we prevent it: Benefits investigation confirms auth, formulary status, medical versus pharmacy routing, and site-of-care rules before the drug is ordered.
Same-day office visit bundled into the infusion
How we prevent it: Modifier 25 is applied where a distinct evaluation is documented separately from the infusion supervision, so both services pay.
Hematology Billing FAQs
Per CPT rules, only one 'initial' administration code is billed per encounter (chemotherapy ranks above therapeutic infusions, which rank above hydration) and everything else bills as sequential or additional-hour add-ons. Coding two initials, or the wrong one, denies or underpays the entire visit's administration revenue.
Medicare requires JW to report discarded drug from single-dose vials and JZ to attest no waste. Missing or inconsistent waste reporting triggers claim rejections and, worse, invites drug-billing audits, while unreported waste on expensive agents is pure lost reimbursement.
A biologic can cost thousands per dose under buy-and-bill. If prior auth wasn't secured, the payer changed formulary, or the drug should have gone through the pharmacy benefit instead of the medical benefit, the practice eats the drug cost. We verify coverage pathway, auth, and site-of-care rules before the chair is booked.
Infusion-based specialties typically price at 4% to 7% of collections. The percentage matters less here than the error rate: with drug costs running into thousands per dose, a single prevented unit-mismatch or unauthorized administration can cover months of billing fees.
Yes, and it's the most consequential work in the specialty. We confirm authorization, formulary status, whether the drug belongs on the medical or pharmacy benefit, and any site-of-care restriction before administration. Getting that sequence right is what keeps buy-and-bill economics viable.
Yes. Infusion AR is usually dominated by a handful of high-dollar claims denied on units, waste reporting, or authorization, which means recovery work has unusually high value per claim. We triage by dollar amount and timely-filing deadline, appeal or correct what's recoverable, and close the upstream gap that caused it.
Ready to Transform Your Hematology Practice?
Trust Astral Medical Services for your Hematology practice's billing and digital marketing needs.